RANKINGS

Key list: leading companies in China and Hong Kong by revenue

Powered by 

This month our pharma industry key list brings you the 15 leading companies in China and Hong Kong by revenue, as ranked by GlobalData's Pharma Intelligence Centre. All numbers up to date as of September 2021.

Company name

Headquarters location  

No. of employeesRevenue ($m)

Sino Biopharmaceutical Ltd

Hong Kong

24,2623,509

Jiangsu Hengrui Medicine Co Ltd

China28,9033,372

CSPC Pharmaceutical Group Ltd

China21,5273,200

Zhejiang Hisun Pharmaceutical Co Ltd

China8,4461,603

Chongqing Zhifei Biological Products Co Ltd

China3,3801,533

The United Laboratories International Holdings Ltd

Hong Kong13,0001,215

Luye Pharma Group Ltd

China4,963920

Yichang Hec Changjiang Pharmaceutical Co Ltd

China4,766901

China Medical System Holdings Ltd

China4,884879

3SBio Inc

China5,584770

China Biologic Products Holdings Inc

China2,269504

BeiGene Ltd

China6,400428

Sihuan Pharmaceutical Holdings Group Ltd

China4,354418

Sinovac Biotech Ltd

China1,959246

Hutchmed China Ltd

Hong Kong1,280205
Go to article: Home | Unpacking innovation in biologics Go to article: In this issueGo to article: ContentsGo to article: MyonexGo to article: Controlant Company InsightGo to article: ControlantGo to article: SHL MedicalGo to article: LabcorpGo to article: ReutersGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: TQS Integration Company InsightGo to article: TQS IntergrationGo to article: Biesterfeld Go to article: CommentGo to article: Biotech and China: a global opportunityGo to article: Intranasal ketamine could effectively treat phantom painGo to article: EU biosimilar wave slows as biosimilar approvals decrease in the EUGo to article: Biosynth Carbosynth Company InsightGo to article: Biosynth CarbosynthGo to article:  Molnár-Institute Company Insight Go to article: Molnar-InstituteGo to article: SkyepharmaGo to article: In DepthGo to article: Unpacking the complex challenge of biologicsGo to article: Living medicines: using bacteria to fight cancerGo to article: The marred history of HIV vaccine trialsGo to article: Has Covid-19 exposed the weakness of the US pharma supply chain?Go to article: How the pandemic pushed pharmacovigilance to innovateGo to article: ExeVir: the llama-derived antibody that could fight Covid-19Go to article: BEA TechnologiesGo to article: WatlowGo to article: DuojectGo to article: ButterworthGo to article: In DataGo to article: Data: Big Data hiring efforts in pharmaGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue